Vitamin B₆ and Its Role in Cell Metabolism and Physiology.
Parra M, Stahl S, Hellmann H. · 2018
Read Vitamin B₆ and Its Role in Cell Metabolism and Physiology. by Parra M, Stahl S, Hellmann H. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6071262.txt.
Introduction
Parra and co-authors review vitamin B6 and its place in cell life. Their review appeared in Cells. The vitamin serves as a cofactor in over 140 cell reactions. Most involve amino acid building and breakdown. Its active form is called PLP.
New work goes past the classic cofactor role. The review explains how cells make and control the vitamin. Two separate build paths exist across species. The vitamin can also quench reactive oxygen species. Links reach human health, pathogen defense, and stress tolerance in plants. Open questions close the survey. Readers get a modern map of a central small molecule.
Catalog record
| CREATOR | Parra M, Stahl S, Hellmann H. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Vitamin B6 and Its Role in Cell Metabolism and Physiology By Marcelina Parra, Seth Stahl, Hanjo Hellmann Published in: Cells DOI: 10.3390/cells7070084 ABSTRACT Abstract Vitamin B6 is one of the most central molecules in cells of living organisms. It is a critical co-factor for a diverse range of biochemical reactions that regulate basic cellular metabolism, which impact overall physiology. In the last several years, major progress has been accomplished on various aspects of vitamin B6 biology. Consequently, this review goes beyond the classical role of vitamin B6 as a cofactor to highlight new structural and regulatory information that further defines how the vitamin is synthesized and controlled in the cell. We also discuss broader applications of the vitamin related to human health, pathogen resistance, and abiotic stress tolerance. Overall, the information assembled shall provide helpful insight on top of what is currently known about the vitamin, along with addressing currently open questions in the field to highlight possible approaches vitamin B6 research may take in the future. Keywords: cell, health, metabolism, pathogen, PLP, physiology, pyridoxine, stress, vitamin B6 1. INTRODUCTION Vitamin B6 (vitB6), or pyridoxine, is a very important compound for general cellular metabolism [1]. Since its discovery in 1934 by György and colleagues [2], it has been implicated as a co-factor in more than 140 biochemical reactions in the cell [3]. Although most vitB6 co-catalyzed reactions are related to amino acid biosynthesis and catabolism, vitB6 also contributes to fatty acid biosynthesis, breakdown of certain storage compounds in animals and plants, as well as in the biosynthesis of plant hormones, neurotransmitters, and organelle-specific compounds such as chlorophyll [4,5,6,7,8,9,10]. In addition, vitB6 can quench reactive oxygen species (ROS) [11]. Because of its role in ROS scavenging and chlorophyll synthesis, vitB6 is beneficial for photosynthesis, and is discussed as a possible factor to alleviate abiotic and biotic stress [11]. The vitamin comprises a group of six chemically related compounds that all contain a pyridine ring as their core. They differ from each other in a variable group at the pyridine’s 4′ position, which can either be an amino methyl group (pyridoxamine (PM)), a hydroxyl methyl group (pyridoxine (PN)), or an aldehyde (pyridoxal (PL)) (Figure 1). Once the different derivatives are phosphorylated, they can function as co-factors, with pyridoxal 5′-phosphate (PLP) being the biologically active form of vitB6. [Figure: Chemical structures of the six common B6 vitamers. (a,b): Pyridoxal (a) and its phosphorylated form pyridoxal 5′-phosphate (b), (c,d): pyridoxamine (c) and pyridoxamine 5′-phosphate (d), (e,f): pyridoxine (e) and pyridoxine 5′-phosphate (f).] In the following review, we will briefly summarize the known biosynthetic pathways in eu- and prokaryotes, and then focus on transport, cellular roles, potential regulatory steps that affect its rate of synthesis, and its importance in human dietary and health issues. For many years the only biosynthetic pathway known came from the prokaryote Escherichia coli. The pathway is comparably complex, but ultimately leads to the pyridoxine biosynthesis proteins A (PDXA; a 4-hydroxythreonine-4-phosphate dehydrogenase) and PDXJ (a pyridoxine 5′-phosphate synthase) that utilize deoxyxylose 5′-phosphate (DXP) and 4-phospohydroxy-L-threonine to synthesize pyridoxine 5′-phosphate (PNP). A flavin mononucleotide (FMN)-dependent PNP oxidase (PNPox) then converts PNP to PLP (Figure 2) [12,13,14]. An alternative pathway was only relatively recently discovered in fungi; plants; and some bacteria that uses a 3-carbon sugar (either glyceraldehyde 3′-phosphate or dihydroxyacetone phosphate), a pentose-phosphate (either ribose 5′-phosphate or ribulose 5′-phosphate), and glutamine to synthesize PLP [15,16]. Two critical enzymes called PDX1 and PDX2 form a larger PLP synthase complex to catalyze the formation of the vitamin [15,16,17,18]. This newer pathway is commonly referred to as the deoxyxylose 5′-phosphate (DXP)-independent pathway, to distinguish it from the biosynthetic pathway present in E. coli that depends on deoxyxylose 5′-phosphate as a precursor (Figure 2). Of note is that humans and most animals do not encode for any of the de novo enzymes, but rely solely on external supplies of the vitamin from their food. As such, vitB6 is an essential nutrient to humans. [Figure: The two known de novo pathways leading to the biosynthesis of PLP. The two de novo pathways, DXP-dependent and -independent, use pyridoxine 5′-phosphate synthase (PDXJ) and 4-hydroxythreonine-4-phosphate dehydrogenase (A) and PDX1 and 2 enzyme, respectively, to synthesize PLP. DXP, Deoxyxylose 5′-phosphate; DAP, Dihydroxyacetone phosphate; DXP, 1-Deoxyxylulose-5-phosphate; GAP, Glyceraldehyde-3-phosphate; GLN, L-Glutamine; GLU, L-Glutamate; PHT, 4-Phosphohydroxy-L-threonine; PLP, Pyridoxal-5-phosphate; PNP, Pyridoxine-5-phosphate; RIP, Ribose-5-phosphate; RUP, Ribulose-5-phosphate.] The importance of the de novo pathway is emphasized by various studies in E. coli, Streptococcus pneumonia, Bacillus subtilis, yeast, and plants where its complete loss is lethal to the organism, but can be rescued by an exogenous supply of the vitamin [17,18,19,20,21,22,23,24]. Even a reduction in the biosynthetic efficiency causes severe developmental problems. For example, the plant Arabidopsis thaliana has two functional homologs of PDX1 involved in the de novo biosynthesis of vitB6 [16,18]. Both PDX1 proteins are expressed throughout the plant and appear to be mostly functionally redundant [18,19,25]. However, Arabidopsis null mutants affected in either one of the two PDX1 proteins show severe developmental defects, including stunted root growth, smaller rosette leaves, delayed flowering [17,18], and considerably larger cells, compared with wild-type [26]. Plants also developed larger seeds with increased protein, lipid, and carbohydrate contents [26]. In addition to the two known de novo pathways, most, if not all, organisms have a salvage pathway that is able to convert and phosphorylate the different B6 vitamin derivatives into the catalytically active form, PLP. This is accomplished by the combined activities of at least three enzymes, an oxidase (PDXH), a pyridoxal reductase (PRL), and a kinase (PDXK) (Figure 3) [27,28,29,30]. At least two different kinases have been described that are either specific for PL (further referred to as PLK), or which recognize PN, PM, and PL as substrates (further referred to as PDXK), to generate the phosphorylated B6 vitamers [28,29,31]. The oxidase catalyzes the conversion of PNP and PMP to PLP [32,33], and the reductase forms PN from PL [34]. [Figure: The VitB6 salvage pathway. The salvage pathway is used to derivatize and phosphorylate B6 vitamers, leading to PLP synthesis via oxidase (PDXH), kinase (K), and pyridoxal reductase (PRL) enzymes.] The salvage pathway is critical to make any non-phosphorylated B6 vitamers available to the cell as co-factors. This is generally relevant for PL, PM, or PN taken up with food and for their recycling in the cell. Consequently, it is essential for animals that depend on the pathway to interconvert the different B6 vitamers into PLP and to make them available as co-factors in enzymatic reactions. In addition, cellular phosphatases have been described that can de-phosphorylate PLP [35]. This may be needed to control the homeostasis of PLP in the cell, and can allow PL catabolism into 4-pyridoxic acid by an aldehyde oxidase [36]. In the liver of mammals, PLP becomes tightly bound to serum albumin as a Schiff base before being secreted into the circulatory blood system for delivery to the different tissues and organs [37,38]. Binding to albumin is discussed as a protective step against early de-phosphorylation of the vitamin. However, before uptake into the cell, PLP needs to be de-phosphorylated to PL by an extracellular, tissue-nonspecific alkaline phosphatase (ALP) [39,40,41]. As ALP only uses free PLP as a substrate, the uptake of PL is likely dependent